Calendar Pharming Group N.V.

Equities

PHARM

NL0010391025

Real-time Euronext Amsterdam 12:38:10 2024-03-28 pm EDT 5-day change 1st Jan Change
1.019 EUR +0.99% Intraday chart for Pharming Group N.V. -2.77% -1.16%

Chart calendar Pharming Group N.V.

40f94b294339b9f457e04.1E0bHc-apWQdotq1_tM83vN74M1FGL2JGQbZm-q3uRI.lztCd6T1-hIp1ojviLh56L0ZrKsJKfH6eGuJ99yE_kqaAl4louLOAHT2vQ~e58972680b3864ffb07a6ef495ceaab1

Upcoming events on Pharming Group N.V.

2024-05-08 01:00 am Q1 2024 Earnings Release
2024-05-20 Annual General Meeting
2024-08-01 01:00 am Q2 2024 Earnings Release
2024-10-24 01:00 am Q3 2024 Earnings Release
2025-03-12 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)
2025-07-30 Q2 2025 Earnings Release (Projected)
2025-10-22 Q3 2025 Earnings Release (Projected)

Past events on Pharming Group N.V.

2024-03-14 08:30 am Q4 2023 Earnings Call
2024-03-14 02:00 am Q4 2023 Earnings Release
2024-02-27 UBS European Healthcare Conference
2024-02-27 Morgan Stanley European MedTech and Life Sciences Conference
2024-02-13 11:20 am Oppenheimer Healthcare Life Sciences Conference
2023-11-14 08:35 am Stifel Healthcare Conference
2023-11-14 03:30 am Jefferies London Healthcare Conference
2023-11-12 03:15 pm American College of Allergy, Asthma & Immunology Scientific Meeting - Poster #M150
2023-11-11 03:35 pm American College of Allergy Asthma & Immunology Scientific Meeting - Poster #P166
2023-11-11 03:20 pm American College of Allergy Asthma & Immunology Scientific Meeting - Poster #P165
2023-11-10 06:00 pm American College of Allergy Asthma & Immunology Scientific Meeting - Poster #M234
2023-11-10 09:15 am International Primary Immunodeficiencies Congress - Poster #152
2023-11-09 04:00 am International Primary Immunodeficiencies Congress - Poster #214
2023-11-09 02:00 am International Primary Immunodeficiencies Congress - Poster #204
2023-10-26 07:30 am Q3 2023 Earnings Call
2023-10-26 01:00 am Q3 2023 Earnings Release
2023-09-28 10:20 am Cantor Global Healthcare Conference
2023-09-25 08:00 am Extraordinary Shareholders Meeting
2023-09-13 08:30 am H.C. Wainwright Global Investment Conference
2023-09-07 04:30 pm Wells Fargo Healthcare Conference

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million EUR
Released
Forecast
Spread
135
136
-0.88%
169
170
-0.71%
186
184
1.18%
181
178
1.35%
195
194
0.35%
224
226
-0.84%
EBITDA
Million EUR
Released
Forecast
Spread
44,6
46,0
-3.07%
66,1
61,7
7.16%
75,7
74,8
1.25%
51,4
43,5
17.99%
29,8
30,1
-0.88%
9,63
2,48
288.33%
EBIT
Million EUR
Released
Forecast
Spread
38,0
43,4
-12.54%
60,9
57,0
6.91%
67,4
69,4
-2.89%
33,5
25,7
30.56%
17,3
22,6
-23.39%
-4,92
-7,59
35.12%
Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
0,86
20,2
-95.76%
46,7
42,3
10.24%
39,3
44,7
-12.05%
21,0
25,2
-16.8%
14,2
43,0
-66.93%
-11,0
-5,14
-113.56%
Net income
Million EUR
Released
Forecast
Spread
25,0
21,4
16.71%
36,2
30,3
19.58%
32,7
31,5
3.61%
14,5
17,1
-15.09%
13,0
33,7
-61.53%
-9,25
-3,75
-146.33%
EPS
EUR
Released
Forecast
Spread
0,04
0,03
13.57%
0,05
0,05
13.68%
0,05
0,05
-5.44%
0,02
0,05
-56.17%
0,00
0,00
-
0,00
-0,01
-
Announcement Date07/03/1905/03/2004/03/2117/03/2216/03/2314/03/24

Quarterly results

Fiscal PeriodDecember 2019 S1 2020 S1 2021 Q2 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3
Net sales
Million EUR
Released
Forecast
Spread
77,9
75,4
3.35%
88,6
101
-12.28%
41,3
47,6
-13.37%
78,7
84,4
-6.7%
45,6
46,2
-1.21%
62,4
50,8
22.95%
44,2
44,3
-0.18%
49,0
50,8
-3.46%
94,6
95,6
-1.11%
53,9
53,6
0.46%
51,8
54,0
-3.99%
38,8
44,7
-13.32%
50,2
48,4
3.79%
89,1
88,0
1.24%
63,0
56,3
11.85%




64,3


66,1





66,1

EBIT
Million EUR
Released
Forecast
Spread






9,18
16,8
-45.35%



9,74
11,2
-13.13%
7,61
3,97
91.58%



17,4
5,93
193.71%



7,71
1,51
411.74%
-9,66
0,81
-1289.41%
-12,4
-0,19
-6591.93%
4,85
-0,80
709.22%



1,79
-1,54
216.54%

-3,76


1,88


-1,99





54,9

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
18,7
19,9
-6.22%
25,9
26,3
-1.54%
6,11
11,6
-47.53%
16,9
22,5
-24.91%
1,14
6,40
-82.18%
3,58
3,81
-5.86%
4,02
-3,09
229.77%
19,1
6,63
188.3%
23,3
10,4
124.23%
9,22
5,14
79.32%
-17,2
6,36
-369.94%
-15,2
-3,03
-400.66%
3,10
-7,03
144.05%
-12,2
-24,5
50.31%
3,12
-8,16
138.19%

5,24


6,85


5,37


22,0


29,8

Net income
Million EUR
Released
Forecast
Spread
13,6
13,8
-1.49%
18,1
17,8
1.93%
4,92
9,11
-45.96%
12,1
16,4
-25.92%
-0,36
3,68
-109.81%
3,21
2,75
16.91%
3,28
-4,50
172.97%
15,3
5,45
181.39%
18,8
8,84
112.46%
9,04
2,42
274.25%
-13,9
3,86
-459.83%
-11,1
-3,85
-189.1%
1,21
-10,4
111.6%
-9,96
-26,4
62.25%
3,31
-8,68
138.07%

4,15


6,03


4,55


18,7


28,9

EPS
EUR
Released
Forecast
Spread
0,02
0,02
-4.76%
0,03
0,02
4.17%
0,01
0,01
-43.67%
0,02
0,02
-33.13%
0,00
0,00
-128.67%












0,01
0,01
158.2%






























Announcement Date25/07/1930/07/2005/08/2105/08/2128/10/2117/03/2212/05/2204/08/2204/08/2227/10/2216/03/2311/05/2303/08/2303/08/2326/10/23-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise